196 related articles for article (PubMed ID: 37402248)
1. Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest.
van Lemmen M; Florian J; Li Z; van Velzen M; van Dorp E; Niesters M; Sarton E; Olofsen E; van der Schrier R; Strauss DG; Dahan A
Anesthesiology; 2023 Sep; 139(3):342-353. PubMed ID: 37402248
[TBL] [Abstract][Full Text] [Related]
2. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest.
Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z
Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413
[TBL] [Abstract][Full Text] [Related]
3. The conundrum of polysubstance overdose.
Pergolizzi JV; Dahan A; LeQuang JA; Raffa RB
J Clin Pharm Ther; 2021 Oct; 46(5):1189-1193. PubMed ID: 33460173
[TBL] [Abstract][Full Text] [Related]
4. Opioid-induced respiratory depression in humans: a review of pharmacokinetic-pharmacodynamic modelling of reversal.
Algera MH; Kamp J; van der Schrier R; van Velzen M; Niesters M; Aarts L; Dahan A; Olofsen E
Br J Anaesth; 2019 Jun; 122(6):e168-e179. PubMed ID: 30915997
[TBL] [Abstract][Full Text] [Related]
5. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
Zamani N; Buckley NA; Hassanian-Moghaddam H
Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
[TBL] [Abstract][Full Text] [Related]
6. Understanding and countering opioid-induced respiratory depression.
Bateman JT; Saunders SE; Levitt ES
Br J Pharmacol; 2023 Apr; 180(7):813-828. PubMed ID: 34089181
[TBL] [Abstract][Full Text] [Related]
7. Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement.
Infante AF; Elmes AT; Gimbar RP; Messmer SE; Neeb C; Jarrett JB
Int J Drug Policy; 2024 Feb; 124():104323. PubMed ID: 38232438
[TBL] [Abstract][Full Text] [Related]
8. Treatment of opioid overdose: current approaches and recent advances.
Britch SC; Walsh SL
Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humans.
van Lemmen M; van der Schrier R; Dahan A; van Velzen M; Sarton E; Niesters M
Expert Opin Drug Metab Toxicol; 2023; 19(10):671-679. PubMed ID: 37795596
[TBL] [Abstract][Full Text] [Related]
10. Non-analgesic effects of opioids: opioid-induced respiratory depression.
Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A
Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535
[TBL] [Abstract][Full Text] [Related]
11. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
12. Nalmefene nasal spray (Opvee) for reversal of opioid overdose.
Med Lett Drugs Ther; 2023 Oct; 65(1687):166-167. PubMed ID: 37871116
[No Abstract] [Full Text] [Related]
13. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
[TBL] [Abstract][Full Text] [Related]
14. Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression.
Dahan A; Aarts L; Smith TW
Anesthesiology; 2010 Jan; 112(1):226-38. PubMed ID: 20010421
[TBL] [Abstract][Full Text] [Related]
15. Zimhi - a higher-dose injectable naloxone for opioid overdose.
Med Lett Drugs Ther; 2022 Apr; 64(1648):61-62. PubMed ID: 35436775
[No Abstract] [Full Text] [Related]
16. Naloxone for Opioid Overdose: Comment.
Milas BL; Varon AJ
Anesthesiology; 2024 Apr; 140(4):857. PubMed ID: 38335038
[No Abstract] [Full Text] [Related]
17. Naloxone for Opioid Overdose: Comment.
Pattullo GG
Anesthesiology; 2024 Apr; 140(4):856. PubMed ID: 38335034
[No Abstract] [Full Text] [Related]
18. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.
Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A
Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561
[TBL] [Abstract][Full Text] [Related]
19. Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit.
Pergolizzi JV; Dahan A; Ann LeQuang J; Raffa RB
J Clin Pharm Ther; 2021 Dec; 46(6):1501-1504. PubMed ID: 34111307
[TBL] [Abstract][Full Text] [Related]
20. [Opioid overdose prevention and naloxone diffusion (POP program): Results of an overview conducted among addiction specialized centres].
Mezaache S; Turlure F; Fredon N; Le Brun Gadelius M; Micallef J; Frauger E
Therapie; 2023; 78(6):605-614. PubMed ID: 37012152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
